- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/64 - Oxygen atoms
Patent holdings for IPC class C07D 333/64
Total number of patents in this class: 94
10-year publication summary
|
8
|
10
|
10
|
9
|
7
|
8
|
9
|
5
|
6
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Board of Trustees of the University of Illinois | 2753 |
13 |
| Novartis AG | 10175 |
8 |
| BioCryst Pharmaceuticals, Inc. | 185 |
7 |
| Radius Pharmaceuticals, Inc. | 56 |
5 |
| Arcus Biosciences, Inc. | 166 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 876 |
4 |
| Merck Patent GmbH | 5739 |
3 |
| Genzyme Corporation | 1383 |
3 |
| Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 36 |
3 |
| Sutro Biopharma, Inc. | 186 |
3 |
| Board of Regents, The University of Texas System | 6149 |
2 |
| Antabio SAS | 23 |
2 |
| Cayman Chemical Company, Incorporated | 55 |
2 |
| Sanford Burnham Prebys Medical Discovery Institute | 308 |
2 |
| Nikang Therapeutics, Inc. | 108 |
2 |
| Merck Sharp & Dohme Corp. | 2184 |
1 |
| Bayer Pharma AG | 1009 |
1 |
| FUJIFILM Corporation | 30628 |
1 |
| Takeda Pharmaceutical Company Limited | 2699 |
1 |
| Cadila Healthcare Limited | 291 |
1 |
| Other owners | 26 |